Myelodysplastic Syndromes (MDS) is a group of diseases that have a variety of different treatments and outcomes. In this episode, we speak to Dr. Colin Vale of Emory University in Atlanta, GA, about the treatments for MDS, the potential for transforming into acute myeloid leukemia (AML), and new strategies to give patients the quality of care that they deserve.

Podcast: Play in new window | Download

Subscribe: Google Podcasts | Spotify | Pandora | Blubrry | JioSaavn | Podchaser | More

CLICK HERE to participate in our episode survey.

Mentioned on this episode: 

• Myelodysplastic Syndromes (MDS)
• IMerge Phase 3 Study (Imetelstat)
• Classification Systems
• Germline Predisposition Article
• Patient-Doctor Perspectives: Hereditary Myelodysplastic Syndromes (MDS) | The Bloodline with LLS
• International Prognostic Scoring System
• Allogeneic Stem Cell Transplantation

Additional LLS Support Resources: 

• Information Specialists 
• Financial support
• Free telephone/web patient programs 
• Free booklets 
• Clinical Trial Support Center
• Young Adult Resources
• Caregiver support 
• Caregiver Workbook
• Survivorship Workbook
• Online chats 
• LLS Community 
• Support groups 
• Patti Robinson Kaufmann First Connection Program 
• Free Nutrition Consultations

Support for this episode provided by: Taiho Oncology, Inc.